###begin article-title 0
Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling
###end article-title 0
###begin p 1
Conceived and designed the experiments: SP JR IG. Performed the experiments: JR IG. Analyzed the data: SP JR IG. Wrote the paper: SP JR
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Niemann-Pick Type C (NPC) disease is a neurodegenerative disease that is characterized by the accumulation of cholesterol and glycosphingolipids in the late endocytic pathway. The majority of NPC cases are due to mutations in the NPC1 gene. The precise function of this gene is not yet known.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 75 80 <span type="species:ncbi:9606">human</span>
Using cDNA microarrays, we analyzed the genome-wide expression patterns of human fibroblasts homozygous for the I1061T NPC1 mutation that is characterized by a severe defect in the intracellular processing of low density lipoprotein-derived cholesterol. A distinct gene expression profile was identified in NPC fibroblasts from different individuals when compared with fibroblasts isolated from normal subjects. As expected, NPC1 mutant cells displayed an inappropriate homeostatic response to accumulated intracellular cholesterol. In addition, a number of striking parallels were observed between NPC disease and Alzheimer's disease.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Many genes involved in the trafficking and processing of amyloid precursor protein and the microtubule binding protein, tau, were more highly expressed. Numerous genes important for membrane traffic and the cellular regulation of calcium, metals and other ions were upregulated. Finally, NPC fibroblasts exhibited a gene expression profile indicative of oxidative stress. These changes are likely contributors to the pathophysiology of Niemann-Pick Type C disease.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Vanier1">[1]</xref>
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Sturley1">[2]</xref>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
Niemann Pick Type C disease (NPC) is a fatal, autosomal recessive neurodegenerative disease due to mutations in the NPC1 or NPC2 genes [1], [2]. NPC is associated with an inability to process cellular cholesterol, which accumulates together with glycosphingolipids within lysosomes of affected individuals. The disease is often diagnosed in early childhood, with patients typically displaying cerebellar ataxia, difficulty speaking and swallowing, and progressive dementia. Mutations in the NPC1 gene account for approximately 95% of NPC cases.
###end p 9
###begin p 10
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Carstea1">[3]</xref>
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Sever1">[4]</xref>
###xml 333 336 333 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Hua1">[5]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Martin1">[6]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Strutt1">[7]</xref>
###xml 386 389 386 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Altmann1">[8]</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ohgami1">[9]</xref>
###xml 648 651 648 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Vanier1">[1]</xref>
NPC1 is a 1278 amino acid protein with 13 transmembrane domains that is important for normal cholesterol homeostasis [3]. NPC1 transmembrane domains 3-7 comprise a so-called sterol sensing domain that is related to hydroxymethlyglutaryl CoA reductase [4], sterol regulatory element-binding protein cleavage activating protein (SCAP; [5], PATCHED [6], [7]) and NPC1-like protein, NPC1L1 [8]. The NPC1 protein was recently shown to bind cholesterol [9]. Mutations in the NPC1 sterol sensing domain can cause disease, as can mutations throughout the protein, the bulk of which resides within the membrane bilayer or within the lumen of late endosomes [1].
###end p 10
###begin p 11
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Millat1">[10]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Park1">[11]</xref>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
To begin to understand how loss of NPC1 function leads to neurodegeneration, we have examined the global pattern of gene expression in primary fibroblast cells from NPC patients. To avoid possible phenotypic variation between different mutant alleles, we designed our analysis using cells from different individuals who each carried the identical, homozygous mutations within their NPC1 loci. The most common NPC-1 mutation described is I1061T, which accounts for 20% of the alleles in the United Kingdom and France and about 15% in the United States [10], [11] and leads to a severe disruption of cholesterol processing. Homozygous carriers of the I1061T mutation present with a relatively mild neurological form of the disease with onset in juvenile years; importantly, their clinical presentation is homogeneous. In our experimental design, we hoped that gene expression differences between any two individuals would be averaged out, highlighting changes due to this specific mutation at both NPC1 alleles. As shown here, NPC1 fibroblasts showed highly significant differences when compared with normal fibroblast controls. The specific gene expression changes observed provide important clues to the pathophysiology of NPC disease.
###end p 11
###begin title 12
Results and Discussion
###end title 12
###begin p 13
###xml 475 484 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000019-g001">Figure 1A</xref>
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Tusher1">[12]</xref>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Primary skin fibroblasts isolated from four patients homozygous for the I1061T mutation and four control individuals were cultured under identical conditions. RNA was isolated from all samples and hybridized to cDNA microarrays consisting of approximately 43,000 elements representing approximately 36,000 genes. Analysis of the data using a supervised hierarchical clustering method identified a gene expression pattern that was unique and consistent among NPC fibroblasts (Figure 1A). To identify statistically significant gene expression profile changes that are likely to result from the I1061T mutation in the NPC1 gene we used SAM (Significance Analysis of Microarrays; [12]).
###end p 13
###begin p 14
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 442 451 442 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000019-g001">Figure 1B</xref>
###xml 692 699 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000019-g001">Fig. 1B</xref>
###xml 1149 1159 1123 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s004">Dataset S1</xref>
SAM identifies genes with statistically significant changes in expression by assimilating a set of gene-specific t tests. Each gene is assigned a score on the basis of its change in gene expression relative to the standard deviation of repeated measurements for that gene. Genes with scores greater than a threshold are deemed potentially significant. The percentage of such genes identified by chance is defined as the false discovery rate. Figure 1B shows the distribution of the approximately43,000 elements analyzed in this study. Many more genes were found to be significantly up-regulated (3578, red points) than down-regulated (699, green points) when comparing normal and NPC1 cells (Fig. 1B). SAM identified approximately 3600 significant genes in our data set with an estimated false discovery rate of 5%; approximately1300 genes showed >/=1.5 fold up-regulation compared with normal cells. The large number of upregulated genes suggests that NPC cells are compensating to survive under challenging circumstances. An Excel list of all significant genes showing a <2% false discovery rate is included for the reader as a supplemental file (Dataset S1).
###end p 14
###begin p 15
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Tusher1">[12]</xref>
It is important to note that the absolute fold change in the level of a specific transcript need not be high to be highly significant, and to have significant consequences for cell physiology [12]. For many of the genes shown, the potential false discovery rate was less than 1%, and as described below, several of the changes have been verified at the protein level.
###end p 15
###begin p 16
###xml 323 330 323 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t001">Table 1</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Blom1">[13]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Klein1">[14]</xref>
Initial analysis of the upregulated genes confirmed the validity of our experimental protocol, as genes expected to be upregulated in cells lacking NPC1 function were upregulated: for example, the gene encoding NPC2 protein was upregulated 1.7 fold and the gene encoding NPC1-like protein, NPC1L1 was upregulated 1.3 fold (Table 1). This confirms previous work demonstrating the upregulation of NPC2 at the protein level in NPC1 fibroblasts [13], [14].
###end p 16
###begin title 17
Cholesterol Homeostasis
###end title 17
###begin p 18
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Maxfield1">[15]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Horton1">[16]</xref>
In normal cells, cholesterol levels are tightly regulated by a number of mechanisms that include cholesterol uptake, storage and efflux [15]. At the transcriptional level, sterol regulatory element-binding proteins regulate the expression of a large number of genes involved in the synthesis and uptake of cholesterol, fatty acids, triglycerides and phospholipids, as well as NADPH that is needed for lipid and cholesterol synthesis [16]. In the presence of adequate cholesterol in the endoplasmic reticulum (ER), these transcription factors fail to translocate to the nucleus, and genes involved in cholesterol synthesis and uptake are no longer activated.
###end p 18
###begin p 19
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Liscum1">[17]</xref>
###xml 548 555 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t001">Table 1</xref>
NPC cells are well documented in terms of their inability to respond to the accumulation of unesterified cholesterol within late endocytic compartments. In these cells, LDL receptor expression is not down-regulated and consequently, LDL uptake continues to occur despite the increased cellular content of free cholesterol [17]. Microarray analysis confirmed this dysregulation: elevated expression (1.5 fold) of the LDL receptor gene was readily detected in NPC fibroblasts homozygous for the I1061T mutation when compared with normal fibroblasts (Table 1).
###end p 19
###begin p 20
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Frolov1">[18]</xref>
###xml 459 462 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Choi1">[19]</xref>
###xml 630 637 630 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t001">Table 1</xref>
###xml 834 841 834 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t001">Table 1</xref>
###xml 848 852 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-AbeDohmae1">[20]</xref>
Cellular cholesterol is also regulated by Liver X Receptors (LXRs), which are activated by cholesterol-derived oxysterols. LXRs activate target genes that participate in the efflux of cellular cholesterol, including the transporters, ABCA1 and ABCG5/ABCG8. NPC cells are defective in oxysterol generation and subsequent LXR activation [18]. Previous, direct measurements of ABCA1 mRNA indicated significantly less upregulation of ABCA1 gene expression in NPC1-/- cells upon cholesterol addition than observed in wild type cells [19]. ABCA1 and ABCG5 expression levels were altered in NPC cells in accordance with earlier reports (Table 1). In addition, we observed increased expression of ABCA7, a non-LXR regulated transporter that has the ability to support apolipoprotein-mediated release of cellular cholesterol and phospholipid (Table 1, ref. [20]).
###end p 20
###begin p 21
###xml 130 137 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t001">Table 1</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Olkkonen1">[21]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Olkkonen1">[21]</xref>
Increased expression of several proteins from the oxysterol binding protein family (OSBPL3, OSBPL6 and OSBPL8) was also detected (Table 1). One function ascribed to this protein family is non-vesicular cholesterol transfer between the ER and the plasma membrane [21]. Both OSBPL3 and OSBPL6 contain targeting sequences for the ER and plasma membrane. Interestingly, overexpression of the related OSBP2 protein leads to the activation of cholesterol synthesis and LDL receptor upregulation, perhaps by enhancing ER cholesterol efflux [21].
###end p 21
###begin title 22
Links to Neurodegenerative Disease
###end title 22
###begin p 23
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Yamazaki1">[22]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Vincent1">[25]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Runz1">[23]</xref>
###xml 875 879 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Runz1">[23]</xref>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Yamazaki1">[22]</xref>
###xml 965 969 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Burns1">[24]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Vincent1">[25]</xref>
###xml 631 636 <span type="species:ncbi:10090">mouse</span>
As in Alzheimer's disease, defects in the processing of the amyloid precursor protein (APP) are well documented for NPC cells [22]-[25]. APP can be processed via two different pathways. In the non-amyloidogenic pathway, APP is cleaved by alpha-secretase to generate a C-terminal fragment (CTF) followed by cleavage with the gamma-secretase complex, resulting in the generation of two non-amyloidogenic peptides. In the amyloidogenic pathway, APP is cleaved by beta-secretase prior to cleavage with gamma-secretase, generating the Abeta fragments that are associated with amyloid plaque formation. Burns et al. [23] have shown that mouse NPC cells show enhanced gamma secretase activity, leading to increased Abeta, Abeta42 and beta-CTF production. They also noted an alteration in the localization of presenilin 1 to some Rab5-positive, putative early endosomes in NPC cells [23]. Increased levels of Abeta, Abeta 42 and beta-CTF were also reported by others [22], [24], [25].
###end p 23
###begin p 24
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Runz1">[23]</xref>
###xml 296 304 296 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000019-g002">Figure 2</xref>
###xml 577 585 577 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000019-g002">Figure 2</xref>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 552 557 <span type="species:ncbi:9606">human</span>
Consistent with previous analyses of mouse NPC cells [23], we found little difference in the mRNA and protein levels of full length amyloid precursor protein, beta secretases (BACE), or the level of the gamma secretase component, presenilin, in human NPC1 cells compared with normal fibroblasts (Figure 2). At the protein level, Nicastrin polypeptide was increased, which could contribute to increased gamma secretase activity. Importantly, we confirmed a significant increase in the generation of amyloid C-terminal fragments at the protein level, in human NPC-1 fibroblasts (Figure 2).
###end p 24
###begin p 25
###xml 240 247 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t002">Table 2</xref>
###xml 360 368 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000019-g002">Figure 2</xref>
###xml 556 560 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Guenette1">[26]</xref>
###xml 562 566 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Chang1">[27]</xref>
###xml 774 778 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Chang1">[27]</xref>
Additionally, expression of the amyloid beta precursor binding protein 2 (APBB2 or Fe65-like), was upregulated 2.6 fold with high significance (0.1% false discovery rate), and was among the highest upregulated genes in our entire data set (Table 2). This protein is thought to regulate the intracellular transport of the amyloid precursor protein. As shown in Figure 2, both the mRNA and APBB2 protein were upregulated approximately2.5 fold in NPC1 cells as determined by immunoblotting of cell extracts. APBB2 interacts with the cytoplasmic domain of APP [26], [27]. The association of APBB2 with APP is required for subsequent processing of APP CTF's by gamma secretases, and overexpression of APBB2 leads to the increased generation of the amyloidogenic Abeta42 fragment [27]. Upregulation of APBB2 in NPC fibroblasts may contribute to the increased generation of Abeta42 in NPC cells.
###end p 25
###begin p 26
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Grimm1">[28]</xref>
###xml 300 307 300 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t002">Table 2</xref>
Recent work has indicated that Abeta42 may directly activate neutral sphingomyelinases [28]. This activation would potentially increase ceramide generation in NPC1 cells and may be linked to oxidative stress. A neutral sphingomyelinase activating protein mRNA (NSMAF) was upregulated in our dataset (Table 2).
###end p 26
###begin p 27
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t002">Table 2</xref>
###xml 159 166 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t003">Table 3</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Cam1">[29]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Kamal1">[30]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Muresan1">[31]</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t002">Table 2</xref>
Genes encoding LDL receptor-related proteins (LRP1, LRP2 and LRP6) were upregulated 1.8, 2.2 and 2.7 fold, respectively, in NPC fibroblasts (Table 2 and Supp. Table 3). LRP1 interacts with APP and may enhance its internalization, thereby favoring initial intracellular APP cleavage by beta-secretase [29]. APP undergoes axonal transport to nerve terminals in a complex with the signaling protein, MAPK8IP1 in a kinesin-1 dependent manner [30], [31]. A Kinesin-1 component (KLC2) and MAPK8IP1 were all upregulated in NPC cells, and could contribute to the transport of APP in NPC neurons (Table 2). In summary, genes encoding multiple factors that contribute to the generation of amyloid are expressed at higher levels in NPC1 cells.
###end p 27
###begin title 28
Intracellular Calcium Regulation
###end title 28
###begin p 29
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t003">Table 3</xref>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-LaFerla1">[32]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Jeyakumar1">[33]</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Mattson1">[34]</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ueda1">[35]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ekinci1">[36]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Arispe1">[37]</xref>
The expression of a number of calcium-regulated and regulating proteins was increased in NPC fibroblasts (Table 3). These include voltage gated calcium channels such as CACNA1C, calcium dependent protein kinases (CAMK1 and CAMK4), phospholipase C, ryanodine receptor and also calpains (CAPN5). The upregulation of these proteins is consistent with altered cytosolic calcium levels in NPC1 mutant cells. Defects in calcium regulation have been reported for a number of neurodegenerative diseases (see [32], [33] for review). Moreover, Abeta42 has been shown to disrupt intracellular calcium regulation which may play a role in Alzheimer's disease [34]. Abeta increases the activation of L type voltage gated calcium channels [35], [36] and has even been proposed to itself form a cation channel [37].
###end p 29
###begin title 30
Tau protein
###end title 30
###begin p 31
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Auer1">[38]</xref>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t002">Table 2</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Correas1">[39]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Tomizawa1">[41]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Yang1">[42]</xref>
###xml 814 821 814 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t003">Table 3</xref>
One of the major features of both Alzheimer's and NPC diseases is the accumulation of neurofibrillary tangles in the brain. A major component of such tangles is an abnormally phosphorylated form of the microtubule binding protein, tau [38]. Although the mechanism of tangle formation is unknown, phosphorylation of the tau protein C-terminus is thought to disrupt microtubule binding and trigger subsequent aggregation. NPC fibroblasts displayed enhanced expression of a number of kinases that may participate in tau phosphorylation (TTBK1, MAPK8, PRKCG) (Table 2, III; [39]-[41]). Divalent cations such as calcium have also been implicated in the formation of phosphorylated tau aggregates [42]. As discussed earlier, many alterations in gene expression suggest an alteration in calcium homeostasis in NPC cells (Table 3).
###end p 31
###begin p 32
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Appelt1">[43]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Johnson1">[44]</xref>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t002">Table 2</xref>
Transglutaminase catalyzes the formation of insoluble tau aggregates in vitro, and increased transglutaminase activity has been observed in Alzheimer's disease [43], [44]. Transglutaminase 4 is significantly upregulated in NPC fibroblasts, and may contribute to tau aggregation in NPC disease [Table 2).
###end p 32
###begin title 33
Cellular toxicity induced in NPC disease
###end title 33
###begin p 34
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Andersen1">[45]</xref>
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000019-t004">Table 4</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Brion1">[46]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Twig1">[47]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Lambeth1">[48]</xref>
Oxidative stress is a major factor in a variety of neurodegenerative diseases [45]. NPC cells displayed a number of changes in gene expression that are associated with the generation of reactive oxygen and nitrogen species (Table 4). CHGA (chromogranin A), a component of Alzheimer's disease plaques [46], induces nitric oxide efflux from microglia, a key step in neurodegeneration [47]. Components of the phagocytic NADPH oxidase (CYBB, NCF4) that can generate reactive oxygen species were upregulated [48]. Correspondingly, a number of genes that respond to oxidative stress (MT1G, MT3, GPX3 and GSTM2) were also upregulated in NPC fibroblasts.
###end p 34
###begin p 35
###xml 342 346 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Chinopoulos1">[49]</xref>
Components of the mitochondrial electron transport chain were also upregulated. This may indicate a compensatory response to a disruption in electron transport chain function as seen in other neurodegenerative diseases such as Parkinson's. Reduced electron transport chain activity has been associated with reactive oxygen species production [49].
###end p 35
###begin p 36
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Smith1">[50]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Lovell1">[51]</xref>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s001">Table S1</xref>
###xml 544 552 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s002">Table S2</xref>
Altered levels of the metal ions copper, zinc and iron have been observed in Alzheimer's disease. The disruption in steady state levels of iron and copper may play a role in oxidative damage [50], [51]. NPC fibroblasts demonstrated enhanced expression of a wide range of transporters and solute carriers, suggesting that the cells are electro-physiologically challenged (Table S1). Genes involved in iron homeostasis and copper and zinc transport were also upregulated, suggestive of an alteration in the cellular homeostasis of these cations (Table S2).
###end p 36
###begin title 37
Pleiotropic Changes in Membrane Trafficking Factors
###end title 37
###begin p 38
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ganley1">[52]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Cataldo1">[53]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Hook1">[54]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ganley1">[52]</xref>
###xml 834 842 834 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s003">Table S3</xref>
###xml 998 1006 998 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s003">Table S3</xref>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ganley1">[52]</xref>
The increased cholesterol in NPC late endosomes and lysosomes interferes with transport of proteins between these compartments (cf. [52]). Consequently, proteins involved in membrane trafficking and in particular, lysosome biogenesis, may be upregulated to compensate for this defect. The lysosomal hydrolase, cathepsin B, was upregulated in NPC cells. Both cathepsin B and cathepsin D can function as beta-secretase enzymes, and are partially mislocalized to early endosomes in Alzheimer's disease [53], [54]. We have shown elsewhere that in NPC cells, the cation-independent mannose 6-phosphate receptor (CI-MPR) is upregulated 1.6 fold at the protein level, along with two proteins involved in its recycling to the Golgi complex: Rab9 GTPase and the Rab9 effector, p40 [52]. p40 mRNA showed a 1.3 fold upregulation in our dataset (Table S3); CI-MPR and Rab9 were not present among the final array data elements. The cation-dependent (CD)-MPR was upregulated 1.5 fold in our microarray analyses (Table S3). This may be in part to compensate for this protein's rapid degradation in NPC fibroblasts [52].
###end p 38
###begin p 39
###xml 112 120 112 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s003">Table S3</xref>
###xml 682 690 682 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000019.s003">Table S3</xref>
###xml 866 870 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Li1">[55]</xref>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
In addition to the MPR trafficking components, many key factors required for membrane traffic were upregulated (Table S3). This includes as many as 8 Rab GTPases and numerous Rab interacting proteins and GTPase activating proteins (TBC-domain containing proteins), and several coat complexes involved in transport vesicle assembly. Rab proteins are general regulators of membrane traffic and have been of particular interest in NPC-disease, as overexpression of several Rabs appears to reverse the cholesterol accumulation phenotype in cell culture [reviewed in 52]. The BLOC1S1 protein complex that is key in the biogenesis of lysosome related organelles was upregulated 2.4 fold (Table S3), and an AP3-subunit key for synaptic vesicle recycling was also upregulated 1.3 fold. Loss of AP3 leads to hippocampal granule deficiency in mice deficient in this component [55]. A number of so-called SNARE proteins and general membrane traffic components including SEC22 and SEC24 were also upregulated. These latter two proteins participate in protein transport from the endoplasmic reticulum to the Golgi complex.
###end p 39
###begin p 40
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Ko1">[56]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Zhang1">[57]</xref>
Multiple kinesin, myosin and dynein motors were upregulated, perhaps to compensate for the inhibition of vesicle motility characteristic of cells lacking NPC1 function [56], [57]. Additional cytoskeletal regulatory proteins including annexin A13 and A6, ankyrin2, several Rho GTPase activating proteins and actin related protein 3 were all upregulated. Many of these changes likely reflect compensatory responses to cholesterol and sphingolipid accumulation-triggered defects.
###end p 40
###begin title 41
Conclusions
###end title 41
###begin p 42
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Gene expression analysis of fibroblasts from patients with Niemann-Pick type C have revealed many intriguing similarities with classic neurodegenerative diseases. Further study of newly identified candidate genes are likely to reveal important clues to the pathophysiology of this genetic disorder.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
Cells
###end title 44
###begin p 45
###xml 4 10 4 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I1061T</sup>
###xml 199 205 199 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I1061T</sup>
###xml 282 286 <span type="species:ncbi:162683">Mayo</span>
###xml 480 486 <span type="species:ncbi:9913">bovine</span>
NPC1I1061T homozygous fibroblasts GM18453, GM17909 and the heterozygous GM03123 fibroblast cell line containing the I1061T mutation were obtained from Coriell cell repositories (Camden, NJ.) and NPC1I1061T homozygous fibroblasts 83.16 and 59413 were obtained from Dr. John O'Brien (Mayo Clinic, Rochester, MN). Normal skin fibroblasts AG10803, GM09503, GM05659 and GM03726 were obtained from the Coriell Cell Repository. All fibroblasts were cultured in DMEM containing 10% fetal bovine serum. Cells were harvested at 50-70% confluency.
###end p 45
###begin title 46
Microarray procedures and Data analysis
###end title 46
###begin p 47
###xml 508 512 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Sherlock1">[58]</xref>
###xml 569 573 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Alizadeh1">[59]</xref>
###xml 746 750 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Eisen1">[60]</xref>
###xml 894 898 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Tusher1">[12]</xref>
###xml 370 375 <span type="species:ncbi:9606">Human</span>
mRNA was isolated with the FastTrack 2.0 mRNA isolation kit according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). A reference RNA comprised of 10 cell lines was used as the control for each hybridized sample (Stratagene, La Jolla, CA). Both sample and reference RNAs were amplified using the MessageAmp II aRNA amplification kit (Ambion, Austin, TX). Human cDNA microarrays consisting of approximately43,000 elements were obtained from the Stanford University functional genomics facility [58]. Hybridizations were conducted essentially as described [59]. The selected genes had >2 fold intensity ratio/background and were measurable in at least 80% of the data set. The resulting output was grouped by hierarchical clustering [60]. The two sets of genes were analyzed by significance analysis of microarrays (SAM) using 100 iterations in the two-class, unpaired data option [12].
###end p 47
###begin title 48
Immunoblots
###end title 48
###begin p 49
###xml 407 413 <span type="species:ncbi:9986">Rabbit</span>
###xml 481 487 <span type="species:ncbi:9986">rabbit</span>
###xml 530 535 <span type="species:ncbi:10090">Mouse</span>
###xml 582 588 <span type="species:ncbi:9986">Rabbit</span>
Normal (AG10803) or NPC (GM03123) skin fibroblasts were washed 3 times with PBS, followed by incubation with RIPA buffer for 15 min. Lysates were centrifuged at 100,000 x g for 10 min and equal amounts of protein were analysed by immunoblot using commercially available antibodies. Signals were detected by chemiluminescence (Perkin Elmer Life Sciences Inc., Boston, MA). Antibodies and their sources were: Rabbit anti-FE65L1 (APPB2), Dr. Suzanne Guenette, Harvard Medical School; rabbit anti-BACE, Santa Cruz Biotechnology, Inc; Mouse anti-Nicastrin, BD transduction Laboratories; Rabbit anti-PSEN1 and APP-CT, Dr. William Mobley, Stanford School of Medicine.
###end p 49
###begin title 50
Data deposition
###end title 50
###begin p 51
Original microarray data have been deposited in the Stanford Microarray Database:
###end p 51
###begin title 52
Supporting Information
###end title 52
###begin p 53
Gene encoding channels, transporters and solute carriers that are upregulated in NPC fibroblasts.
###end p 53
###begin p 54
(0.07 MB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
Genes involved in metal transport and homeostasis that are upregulated in NPC fibroblasts.
###end p 56
###begin p 57
(0.03 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
Genes involved in membrane traffic and the cytoskeleton that are upregulated in NPC fibroblasts.
###end p 59
###begin p 60
(0.09 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
This excel file presents SAM results for this data set, sorted alphabetically. False discovery rates are all <2%.
###end p 62
###begin p 63
(2.47 MB XLS)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
Thanks to Drs. Gilbert Chu, Patrick Brown, Annika Saaf, and other members of the Brown lab for critical advice.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Niemann-Pick disease type C.
###end article-title 67
###begin article-title 68
The pathophysiology and mechanisms of NP-C disease.
###end article-title 68
###begin article-title 69
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.
###end article-title 69
###begin article-title 70
Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain.
###end article-title 70
###begin article-title 71
Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein.
###end article-title 71
###begin article-title 72
The sterol-sensing domain of Patched protein seems to control Smoothened activity through Patched vesicular trafficking.
###end article-title 72
###begin article-title 73
Mutations in the sterol-sensing domain of Patched suggest a role for vesicular trafficking in Smoothened regulation.
###end article-title 73
###begin article-title 74
Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.
###end article-title 74
###begin article-title 75
Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain.
###end article-title 75
###begin article-title 76
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype.
###end article-title 76
###begin article-title 77
Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1.
###end article-title 77
###begin article-title 78
Significance analysis of microarrays applied to the ionizing radiation response.
###end article-title 78
###begin article-title 79
Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease.
###end article-title 79
###begin article-title 80
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
NPC2 is expressed in human and murine liver and secreted into bile: potential implications for body cholesterol homeostasis.
###end article-title 80
###begin article-title 81
Role of cholesterol and lipid organization in disease.
###end article-title 81
###begin article-title 82
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.
###end article-title 82
###begin article-title 83
Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts.
###end article-title 83
###begin article-title 84
NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols.
###end article-title 84
###begin article-title 85
###xml 70 75 <span type="species:ncbi:9606">human</span>
Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein.
###end article-title 86
###begin article-title 87
Oxysterol binding proteins: in more than one place at one time?
###end article-title 87
###begin article-title 88
Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells.
###end article-title 88
###begin article-title 89
Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells.
###end article-title 89
###begin article-title 90
Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo.
###end article-title 90
###begin article-title 91
Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities.
###end article-title 91
###begin article-title 92
###xml 23 28 <span type="species:ncbi:9606">human</span>
Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.
###end article-title 92
###begin article-title 93
Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1.
###end article-title 93
###begin article-title 94
Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin.
###end article-title 94
###begin article-title 95
Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein.
###end article-title 95
###begin article-title 96
Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I.
###end article-title 96
###begin article-title 97
Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1.
###end article-title 97
###begin article-title 98
Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.
###end article-title 98
###begin article-title 99
Storage solutions: treating lysosomal disorders of the brain.
###end article-title 99
###begin article-title 100
###xml 65 70 <span type="species:ncbi:9606">human</span>
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.
###end article-title 100
###begin article-title 101
Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals.
###end article-title 101
###begin article-title 102
Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration.
###end article-title 102
###begin article-title 103
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.
###end article-title 103
###begin article-title 104
Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease.
###end article-title 104
###begin article-title 105
Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain.
###end article-title 105
###begin article-title 106
Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
###end article-title 106
###begin article-title 107
Tau-tubulin kinase phosphorylates tau at Ser-208 and Ser-210, sites found in paired helical filament-tau.
###end article-title 107
###begin article-title 108
###xml 70 75 <span type="species:ncbi:9606">human</span>
Ca2+ and Mg2+ selectively induce aggregates of PHF-tau but not normal human tau.
###end article-title 108
###begin article-title 109
###xml 48 53 <span type="species:ncbi:9606">human</span>
The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures.
###end article-title 109
###begin article-title 110
Transglutaminase activity is increased in Alzheimer's disease brain.
###end article-title 110
###begin article-title 111
Oxidative stress in neurodegeneration: cause or consequence?
###end article-title 111
###begin article-title 112
Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease.
###end article-title 112
###begin article-title 113
Synergistic amplification of beta-amyloid- and interferon-gamma-induced microglial neurotoxic response by the senile plaque component chromogranin A.
###end article-title 113
###begin article-title 114
NOX enzymes and the biology of reactive oxygen.
###end article-title 114
###begin article-title 115
Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme.
###end article-title 115
###begin article-title 116
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.
###end article-title 116
###begin article-title 117
opper, iron and zinc in Alzheimer's disease senile plaques.
###end article-title 117
###begin article-title 118
Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells.
###end article-title 118
###begin article-title 119
Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.
###end article-title 119
###begin article-title 120
Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.
###end article-title 120
###begin article-title 121
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles.
###end article-title 121
###begin article-title 122
Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events.
###end article-title 122
###begin article-title 123
Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease.
###end article-title 123
###begin article-title 124
The Stanford Microarray Database.
###end article-title 124
###begin article-title 125
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
###end article-title 125
###begin article-title 126
Cluster analysis and display of genome-wide expression patterns.
###end article-title 126
###begin title 127
Figures and Tables
###end title 127
###begin title 128
Gene expression is significantly altered in NPC1 fibroblasts.
###end title 128
###begin p 129
(A) Supervised hierarchical clustering of the top 200 genes after SAM analysis.
###end p 129
###begin p 130
The dendrogram at the top shows clustering of NPC and control fibroblasts into distinct groups.
###end p 130
###begin p 131
Genes with higher expression are shown in red; genes with lower expression are shown in green.
###end p 131
###begin p 132
Gray bars indicate missing data.
###end p 132
###begin p 133
Cell lines clustered in the following order (left to right): control lines AG10803, GM05659, GM09503, GM03726; NPC-1 lines GM017909, 59413, 83.16, and GM18453.
###end p 133
###begin p 134
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000019-Tusher1">[12]</xref>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
(B) Significance Analysis of Microarrays [12] was used to identify genes that varied in expression between NPC fibroblasts and control fibroblasts from healthy patients.
###end p 134
###begin p 135
The plot of the data from 43,000 elements reveals approximately 3600 significant genes that have increased expression in NPC fibroblasts (shown in red).
###end p 135
###begin title 136
Links to Alzheimer's disease at the mRNA and protein levels in NPC Cells.
###end title 136
###begin p 137
Protein levels in control and NPC-1 fibroblasts, determined by immunoblot (panel A), are quantified in B (dark shaded bars); mRNA levels from microarray data are shown in light shaded bars for comparison.
###end p 137
###begin title 138
Genes involved in Cholesterol Homeostasis are upregulated in NPC cells.
###end title 138
###begin title 139
Genes associated with Alzheimer's disease are upregulated in NPC cells.
###end title 139
###begin title 140
Genes associated with calcium regulation are upregulated in NPC fibroblasts.
###end title 140
###begin title 141
Genes involved in oxidative stress that are upregulated in NPC fibroblasts.
###end title 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Ara Parseghian Medical Research Foundation and the NIH (DK37332).
###end p 143

